Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Estramustine vs Mitoxantrone and Prednisone in Prostate Cancer
NCT00004001Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1999
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel in prostate cancer (PCa), sponsored by SWOG Cancer Research Network. Started Oct 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004001.